-
Liz
-
Bio
<
>
Liz obtained her B.A. at Swarthmore College and Ph.D. from the Laboratory of Molecular Pathogenesis at Rockefeller University. She is also an elected fellow of the American Academy of Microbiology and dedicates her research efforts towards transcriptional regulation of Mycobacterium tuberculosis and visualizing SARS-CoV-2 replication-transcription complexes. In addition, she is the recipient of the 2023 Emil von Behring Prize for her work on the SARS-CoV-2 polymerase in complex with the helicase. She is also an avid advocate for social justice, diversity & inclusion, and mentorship.
<
>
Mira graduated from the University of Belgrade, Faculty of Biology-Molecular Biology and Physiology, Serbia. Her interests lie in antibiotic resistance and transcriptional regulation in Mycobacteria.
<
>
Josh attained his B.A. in Political Science from the Claremont Colleges, CA, before pursuing a career in the Washington D.C. beltway. After developing his interest in research science, he began training in biochemistry at Columbia University, NY, where he also began working in the protein crystallography lab of Dr. Lawrence Shapiro; studying cell adhesion molecules in Drosophila melanogaster. He is currently conducting his postdoctoral fellowship at the Rockefeller University, NY, in the lab of Dr. Seth Darst and Dr. Elizabeth Campbell. His research focuses on the structural mechanisms of Bacterial RNA-Polymerase promoter escape and the various functional and structural features of the transcription factor DNA-translocase MFD.
<
>
Jimmi, a Seattle native, earned a dual degree in molecular and cellular biology and public health-environmental health. In Jim Heath's lab, they helped develop a high-throughput targeted drug screening method for novel macrocyclic compounds for cancer and infectious diseases. Funded by the Innovators Award, the project fostered interdisciplinary collaboration to tackle high-risk biological challenges. Jimmi and their team created antimicrobial compounds that modulate the host immune system to target pathogens like K. pneumoniae, S. aureus, and SARS-CoV-2 while discovering inhibitors for cancer targets like c-Myc. Jimmi started their Ph.D in 2023, in the Campbell lab. Their research focuses on the intricate role of epigenetic modifications in the transcription process and how their dysregulation impacts cell biology in mycobacteria. Their work aims to uncover critical insights into how epigenetic shifts can alter fundamental biological mechanisms. Outside the lab, Jimmi is a true explorer. They spend their free time hopping between cafes, photographing life, hiking, fishing, and experimenting with new recipes in the kitchen. If they're not working, you'll likely find them wandering New York City, discovering its hidden gems and soaking in the vibrant atmosphere that makes the city unique.
<
>
Maddie attended the University of Richmond for undergraduate studies, where she majored in Biochemistry and Molecular Biology and minored in Leadership Studies. Her current research focus is on transcriptional regulation in Mycobacterium tuberculosis. |
|
<
>
Yukti was born and raised in New Delhi, India. She earned her bachelor's degree in biotechnology from Delhi in 2018. She did her PhD in the Sashital Lab at Iowa State University. Her thesis work focused on understanding mechanisms of memory formation in CRISPR-Cas adaptive immune systems. She used cryo-EM and biochemistry to demonstrate how Cas4-Cas1-Cas2 complex achieves processing and integration of short DNA sequences into a CRISPR array. She is excited to integrate her interest in transcription from her undergraduate days with cryo-EM from graduate school for her postdoc in the Darst-Campbell lab.
<
>
Max obtained his bachelor's degree in biotechnology in Germany and then his master's in molecular medicine in Austria, where he worked on transcription factors and RNA polymerase II. He started his PhD at Rockefeller University in 2024 and joined the Laboratory of Molecular Pathogenesis to investigate translation initiation in Mycobacteria, as well as how drugs target mycobacterial RNA polymerase. Outside the lab, Max likes to go furniture hunting, enjoy new neighborhoods in NYC and look at beautiful things
<
>
Gabe graduated from Washington University in St. Louis in 2020 with a degree in biochemistry and began his graduate studies at Rockefeller in 2020. He is interested in the structural biology of SARS-CoV-2 replicase machinery, especially the NiRAN domain on nsp12
<
>
Pranav attained his B.S. in Cell and Molecular Biology from Grand Valley State University, MI, where he worked in the lab of Dr. Brian Smith to study the structure and biochemical characteristics of ANT-6b, an enzyme that confers bacteria resistance against aminoglycoside antibiotics. Now an RA in the Campbell lab, Pranav's work focuses on transcriptional regulation in M. tuberculosis. In his free time Pranav likes to cook, lift weights, read, and engage in unrelated yet highly entertaining gossip with his friends, lab mates and roommates. |